EcoDrugPlus

Ensembl ID : YML073C
Description: -
82 Possible Orthologues:

Title

Ensembl ID : YML075C
Description: -
119 Possible Orthologues:

Title

Ensembl ID : YML078W
Description: -
718 Possible Orthologues:

Title

Ensembl ID : YML092C
Description: -
74 Possible Orthologues:

Title

Ensembl ID : YML123C
Description: -
553 Possible Orthologues:

Title

Ensembl ID : YMR001C
Description: -
82 Possible Orthologues:

Title

Ensembl ID : YMR020W
Description: -
109 Possible Orthologues:

Title

Ensembl ID : YMR083W
Description: -
249 Possible Orthologues:

Title

Ensembl ID : YMR121C
Description: -
116 Possible Orthologues:

Title

Ensembl ID : YMR139W
Description: -
141 Possible Orthologues:

Title

Ensembl ID : YMR142C
Description: -
88 Possible Orthologues:

Title

Ensembl ID : YMR143W
Description: -
136 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).